BBHC
Brown Brothers Harriman & Co Portfolio holdings
AUM
$15.6B
1-Year Return
17.71%
This Quarter Return
-6.07%
1 Year Return
+17.71%
3 Year Return
+77.24%
5 Year Return
+124.29%
10 Year Return
+261.89%
AUM
$14.1B
AUM Growth
+$14.1B
(+79,392%)
Cap. Flow
-$332M
Cap. Flow
% of AUM
-2.35%
Top 10 Holdings %
Top 10 Hldgs %
39.75%
Holding
1,346
New
172
Increased
342
Reduced
267
Closed
73
Top Buys
| 1 |
Microsoft
MSFT
|
+$331M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$203M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$163M |
| 4 |
Pool Corp
POOL
|
+$159M |
| 5 |
Clarivate
CLVT
|
+$56.6M |
Top Sells
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$249M |
| 2 |
Brown-Forman Class B
BF.B
|
+$229M |
| 3 |
Colgate-Palmolive
CL
|
+$224M |
| 4 |
Baxter International
BAX
|
+$216M |
| 5 |
Zoetis
ZTS
|
+$113M |
Sector Composition
| 1 | Financials | 21.71% |
| 2 | Industrials | 13.53% |
| 3 | Healthcare | 13.49% |
| 4 | Technology | 10.92% |
| 5 | Consumer Discretionary | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Estee Lauder
EL
$31.5B
| $983K | 0.01% |
3,609
+8
| +0.2% | +$2.18K |
|
|
ZVO
252
DELISTED
Zovio Inc. Common Stock
ZVO
| $966K | 0.01% |
+1,178,400
| New | +$966K |
|
253
iShares S&P 500 Growth ETF
IVW
$65B
| $963K | 0.01% |
12,612
| – | – |
|
254
Vanguard Dividend Appreciation ETF
VIG
$97B
| $959K | 0.01% |
5,916
-791
| -12% | -$128K |
|
255
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11.3B
| $938K | 0.01% |
16,869
| – | – |
|
256
S&T Bancorp
STBA
$1.49B
| $931K | 0.01% |
31,473
| – | – |
|
257
RLI Corp
RLI
$6.08B
| $927K | 0.01% |
16,766
| – | – |
|
258
Stryker
SYK
$146B
| $924K | 0.01% |
3,456
-4,312
| -56% | -$1.15M |
|
259
Entegris
ENTG
$12B
| $921K | 0.01% |
7,016
+494
| +8% | +$64.8K |
|
260
Vaxcyte
PCVX
$4.15B
| $918K | 0.01% |
38,033
| – | – |
|
261
Vanguard S&P Small-Cap 600 ETF
VIOO
$3.01B
| $903K | 0.01% |
9,122
| – | – |
|
262
Verisk Analytics
VRSK
$36.7B
| $899K | 0.01% |
4,188
+3,026
| +260% | +$650K |
|
263
Arista Networks
ANET
$189B
| $889K | 0.01% |
25,596
+1,840
| +8% | +$63.9K |
|
264
Crown Castle
CCI
$40.9B
| $886K | 0.01% |
4,802
+525
| +12% | +$96.9K |
|
265
Vulcan Materials
VMC
$38.9B
| $886K | 0.01% |
4,824
-532
| -10% | -$97.7K |
|
266
Charles River Laboratories
CRL
$7.54B
| $881K | 0.01% |
3,104
+460
| +17% | +$131K |
|
267
Organon & Co
OGN
$2.67B
| $880K | 0.01% |
25,183
-780
| -3% | -$27.3K |
|
268
T-Mobile US
TMUS
$271B
| $878K | 0.01% |
6,843
+6,037
| +749% | +$775K |
|
269
International Paper
IP
$24.5B
| $872K | 0.01% |
18,886
+1,804
| +11% | +$83.3K |
|
270
Vanguard High Dividend Yield ETF
VYM
$64.7B
| $860K | 0.01% |
7,664
| – | – |
|
|
PRTK
271
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $855K | 0.01% |
287,902
| – | – |
|
272
Charter Communications
CHTR
$35.9B
| $826K | 0.01% |
1,514
-191
| -11% | -$104K |
|
273
Watsco
WSO
$15.8B
| $826K | 0.01% |
2,710
+231
| +9% | +$70.4K |
|
274
Molson Coors Class B
TAP
$9.7B
| $817K | 0.01% |
15,305
| – | – |
|
275
Sarepta Therapeutics
SRPT
$1.8B
| $810K | 0.01% |
10,370
| – | – |
|